The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane

The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane - The diagnosis of pleuroperitoneal communication by contrast enhanced ultrasonography with perflubutane

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016358

Enrollment

Registered

2015-01-28

Start date

2015-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hydrothorax

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with hydrothorax and ascites

Exclusion criteria

Exclusion criteria: patients with egg allergy

Design outcomes

Primary

Measure	Time frame
The assessment of the diagnostic rate of pleuroperitonal communication by contrast enhanced ultrasonography	—

Countries

Japan

Contacts

Public ContactMasahiko Koda

Tottori University, School of Medicine Division of Medicine and Clinical Science, Department of Multidisciplinary Internal Medicine,

masakoda89@yahoo.co.jp0859-38-6527

Outcome results